OncoHealth · 4 days ago
Case Review Specialist
OncoHealth is a leading digital health company dedicated to helping health plans, employers, providers, and patients navigate the complexities of cancer through technology-enabled services. The Case Review Specialist ensures accurate and timely case documentation and facilitates discussions between clinical and non-clinical staff.
AppsHealth CareInformation TechnologyMedicalOncology
Responsibilities
Flexible to work rotational shifts inside our office hours from 8:00 a.m. – 8:00 p.m. EST to cover the operational needs of the company. Shifts can range anywhere between Monday – Friday 8:00 am to 8:00 pm EST and Saturdays 8:30 am - 6 pm EST (Office hours may change/extend upon operational needs)
Process cases and request/maintain clinical documentation and transmit timely determinations via the company’s internal system and/or by phone to the provider and/or member and/or payer
Intake Pre-Authorization requests and/or inquiries on existing pre-authorizations via phone, email, fax or by the portal and ensuring they are responded/processed within the established metrics
Work collaboratively with clinical and non-clinical staff to facilitate case discussions
Fax intake and labeling on weekends/Holidays as needed
Qualification
Required
Bachelor's Degree or relevant experience preferred
A minimum of 2-4 years' administrative experience and/or customer service or relevant educational attainment required
Implementation of systems for program effectiveness and productivity required
Systems/Tools: MS Office Suite proficient
Preferred
Experience working remote independently
Knowledge in pre-authorizations and health insurance client services departments are preferred
Benefits
Full benefit package
Company bonus
Company
OncoHealth
OncoHealth is a digital health company that focuses on navigating the physical, mental, and financial complexities of cancer care.
Funding
Current Stage
Growth StageTotal Funding
$56.5MKey Investors
Baird CapitalOak HC/FTThe Blue Venture Fund
2022-05-09Private Equity
2020-05-26Series C· $28M
2018-11-05Series B· $21M
Recent News
Company data provided by crunchbase